Antidepressant monotherapy and combination of antidepressants in the treatment of resistant depression in current clinical practice: A retrospective study

References

• Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593–602.
   PubMed Web of Science ®Google Scholar
• Fava M. Management of nonresponse and intolerance: Switching strategies. J Clin Psychiatry 2000;61(Suppl 2):10–2.
   Google Scholar
• Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, . Evaluation of outcomes with citalopram for depression using measurement-based care in Star*D: Implications for clinical practice. Am J Psychiatry 2006;163:28–40.
   PubMed Web of Science ®Google Scholar
• Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, . Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A Star*D report. Am J Psychiatry 2006; 163:1905–17.
   PubMed Web of Science ®Google Scholar
• Souery D, Amsterdam J, De MC, Lecrubier Y, Montgomery S, Lipp O, . Treatment resistant depression: Methodological overview and operational criteria. Eur Neuropsychopharmacol 1999;9:83–91.
   PubMed Web of Science ®Google Scholar
• Nierenberg AA, Katz J, Fava M. A critical overview of the pharmacologic management of treatment-resistant depression. Psychiatr Clin N Am 2007;30:13–29.
   PubMed Web of Science ®Google Scholar
• Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, . Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association For Psychopharmacology Guidelines. J Psychopharmacol 2008;22:343–96.
   PubMed Web of Science ®Google Scholar
• Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M, . World Federation Of Societies Of Biological Psychiatry (WFSBP) Guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry 2007;8:67–104.
   PubMed Web of Science ®Google Scholar
• Dodd S, Horgan D, Malhi GS, Berk M. To combine or not to combine? A literature review of antidepressant combination therapy. J Affect Disord 2005;89:1–11.
   PubMed Web of Science ®Google Scholar
• Rosenzweig-Lipson S, Beyer CE, Hughes ZA, Khawaja X, Rajarao SJ, Malberg JE, . Differentiating antidepressants of the future: Efficacy and safety. Pharmacol Ther 2007;113: 134–53.
   PubMed Web of Science ®Google Scholar
• Rush AJ. Limitations in efficacy of antidepressant monotherapy. J Clin Psychiatry 2007;68(Suppl 10):8–10.
   PubMedGoogle Scholar
• Horgan D, Dodd S, Berk M. A survey of combination antidepressant use in Australia. Australas Psychiatry 2007;15: 26–9.
   PubMed Web of Science ®Google Scholar
• Joffe RT. Combined treatments for major depression. Expert Opin Investig Drugs 2007;16:1379–89.
   PubMed Web of Science ®Google Scholar
• Keks NA, Burrows GD, Copolov DL, Newton R, Paoletti N, Schweitzer I, . Beyond the evidence: Is there a place for antidepressant combinations in the pharmacotherapy of depression? Med J Aust 2007;186:142–4.
   PubMed Web of Science ®Google Scholar
• Carpenter LL, Yasmin S, Price LH. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine. Biol Psychiatry 2002;51:183–8.
   PubMed Web of Science ®Google Scholar
• Fava M, Alpert J, Nierenberg A, Lagomasino I, Sonawalla S, Tedlow J, . Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine. J Clin Psychopharmacol 2002;22:379–87.
   PubMed Web of Science ®Google Scholar
• Licht RW, Qvitzau S. Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation. Psychopharmacology (Berlin) 2002;161:143–51.
   PubMed Web of Science ®Google Scholar
• Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, . Medication augmentation after the failure of SSRIs for depression. New Engl J Med 2006;354: 1243–52.
   PubMed Web of Science ®Google Scholar
• Blier P, Ward HE, Tremblay P, Laberge L, Hébert C, Bergeron R. Combination of antidepressant medications from treatment initiation for major depressive disorder: A double-blind randomized study. Am J Psychiatry 2010;167: 281–8.
   PubMed Web of Science ®Google Scholar
• Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry 2002;159:469–73.
   PubMed Web of Science ®Google Scholar
• Zimmerman M, Chelminski I, Posternak MA. Generalizability of antidepressant efficacy trials: Differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial. Am J Psychiatry 2005;162:1370–2.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th. Washington, DC: American Psychiatric Press; 2004.
   Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, . The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV And ICD-10. J Clin Psychiatry 1998;59(Suppl 20):22–33.
   PubMed Web of Science ®Google Scholar
• Thase ME, Rush AJ. When at first you don't succeed: Sequential strategies for antidepressant nonresponders. J Clin Psychiatry 1997;58(Suppl 13):23–9.
   PubMed Web of Science ®Google Scholar
• Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, . Bupropion-Sr, sertraline, or venlafaxine-Xr after failure of SSRIs For depression. New Engl J Med 2006;354:1231–42.
   PubMed Web of Science ®Google Scholar
• Papakostas GI, Fava M, Thase ME. Treatment of SSRI-resistant depression: A meta-analysis comparing within-versus across-class switches. Biol Psychiatry 2008;63:699–704.
   PubMed Web of Science ®Google Scholar
• Beck AT, Rial WY, Rickels K. Short form of depression inventory: Cross-validation. Psychol Rep 1974;34:1184–6.
   PubMed Web of Science ®Google Scholar
• Guy W. ECDU Assessment manual for psychopharmacology-revised.: Rockville, MD; US Dept Health, Education And Welfare Publication (Adm) 76–338. 1976. 218.
   Google Scholar
• Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382–9.
   PubMed Web of Science ®Google Scholar
• Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, . Report by the ACNP Task Force On Response And Remission In Major Depressive Disorder. Neuropsychopharmacology 2006; 31:1841–53.
   PubMed Web of Science ®Google Scholar
• Citrome L. Compelling or irrelevant? Using number needed to treat can help decide. Acta Psychiatr Scand 2008;117:412–9.
   PubMed Web of Science ®Google Scholar
• De La Gandara J, Rojo JE, Ros S, Agüera L, De Pedro JM. Neuropharmacological basis of combining antidepressants. Acta Psychiatr Scand 2005;112(Suppl 428):11–3.
   Google Scholar
• Trivedi MH, Hollander E, Nutt D, Blier P. Clinical evidence and potential neurobiological underpinnings on unresolved symptoms of depression. J Clin Psychiatry 2008;69:246–58.
   PubMed Web of Science ®Google Scholar
• Uhr M, Tontsch A, Namendorf C, Ripke S, Lucae S, Ising M, . Polymorphisms in the drug transporter gene Abcb1 predict antidepressant treatment response in depression. Neuron 2008;57:203–9.
   PubMed Web of Science ®Google Scholar
• Lam RW, Kennedy SH, Grigoriadis S, Mcintyre RS, Milev R, Ramasubbu R, . Canadian Network For Mood And Anxiety Treatments (Canmat) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord 2009; 117(Suppl 1):S26–43.
   PubMed Web of Science ®Google Scholar
• Cipriani A, Furukawa TA, Geddes JR, Malvini L, Signoretti A, Mcguire H, . Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis. J Clin Psychiatry 2008;69:1732–42.
   PubMed Web of Science ®Google Scholar
• Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, . Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple-treatments meta-analysis. Lancet 2009;373:746–58.
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Baldwin DS, Blier P, Fineberg NA, Kasper S, Lader M, . Which antidepressants have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol 2007;22:323–9.
   PubMed Web of Science ®Google Scholar
• Stahl SM. Antidepressants. Stahl SM. Stahl's essential psychopharmacology: Neuroscientific basis and practical applications. 3rd. New York: Cambridge University Press; 2008. 511.
   Google Scholar
• Hennings JM, Owashi T, Binder EB, Horstmann S, Menke A, Kloiber S, . Clinical characteristics and treatment outcome in a representative sample of depressed inpatients – Findings from the Munich Antidepressant Response Signature (MARS) Project. J Psychiatr Res 2009;43:215–29.
   PubMed Web of Science ®Google Scholar
• Pridmore S, Turnier-Shea Y. Medication options in the treatment of treatment-resistant depression. Aust NZ J Psychiatry 2004;38:219–25.
   PubMed Web of Science ®Google Scholar
• Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry 2001;62(Suppl 16): 10–7.
   PubMedGoogle Scholar
• Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K, . Clinical factors associated with treatment resistance in major depressive disorder: Results from a European Multicenter Study. J Clin Psychiatry 2007;68: 1062–70.
   PubMed Web of Science ®Google Scholar